BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26881521)

  • 1. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
    Wahal SP; Goel MM; Mehrotra R
    J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
    El-Gendi S; Abdel-Hadi M
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangiogenesis does not occur in breast cancer.
    Agarwal B; Saxena R; Morimiya A; Mehrotra S; Badve S
    Am J Surg Pathol; 2005 Nov; 29(11):1449-55. PubMed ID: 16224211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
    Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
    Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
    Raica M; Cimpean AM; Ceausu R; Ribatti D
    Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma.
    Acs G; Paragh G; Rakosy Z; Laronga C; Zhang PJ
    Mod Pathol; 2012 Feb; 25(2):163-77. PubMed ID: 22020194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
    Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
    Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
    Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
    Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
    Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
    Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
    Lin JY; Li XY; Dong P; Nakashima T
    J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
    Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
    Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Huygelen V; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Nov; 95(10):1362-6. PubMed ID: 17088912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma.
    Guleria P; Srinivas V; Basannar D; Dutta V
    Indian J Pathol Microbiol; 2018; 61(2):176-180. PubMed ID: 29676352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
    Tong L; Yuan S; Feng F; Zhang H
    Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Kurozumi K; Nakahara M; Nakao K; Kakudo K
    J Clin Pathol; 2006 Jan; 59(1):77-82. PubMed ID: 16394285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.